Key points are not available for this paper at this time.
Blood glucose (BG) monitoring devices are coming under regulatory scrutiny because of a growing concern that (1) greater accuracy is needed, especially for use in hospitals and long-term facilities, and (2) various substances can interfere with accurate readings and lead to incorrect insulin dosing and hypoglycemia.
David C. Klonoff (Mon,) studied this question.